CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis

Cancer Biomarkers

Volumn 1, Issue 2-3, 2005, Pages 193-200

  Park, Jong ^a   Brena, Romulo Martin ^b,c   Gruidl, Mike ^a   Zhou, Jun ^a   Huang, Tim ^b   Plass, Christoph ^b   Tockman, Melvyn S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Medical Research Facility   (United States)

Author keywords

CpG islands; Hypermethylation; lung cancer; restriction landmark genomic scanning (RLGS)

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CARCINOMA; CASE CONTROL STUDY; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENOMICS; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; RESTRICTION MAPPING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; FEMALE; GENOMICS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RESTRICTION MAPPING;

EID: 34347405530     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2005-12-307     Document Type: Article

References (45)

1. B.F. Hankey, L.A. Ries and B.K. Edwards, The surveillance, epidemiology, and end results program: a national resource, Cancer Epidemiol Biomarkers Prev 8(12) (1999), 1117-1121.
2. R. Etzioni, N. Urban, S. Ramsey, M. McIntosh, S. Schwartz, B. Reid, J. Radich, G. Anderson and L. Hartwell, The case for early detection, Nat Rev Cancer 3(4) (2003), 243-252.
3. L.X. Clegg, F.P. Li, B.F. Hankey, K. Chu and B.K. Edwards, Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study, Arch Intern Med 162(17) (2002), 1985-1993.
4. D.J. Smiraglia and C. Plass, The study of aberrant methylation in cancer via restriction landmark genomic scanningm, Oncogene 21(35) (2002), 5414-5426.
5. L.J. Rush, Z. Dai, D.J. Smiraglia, X. Gao, F.A. Wright, M. Fruhwald, J.F. Costello, W.A. Held, L. Yu, R. Krahe, J.E. Kolitz, C.D. Bloomfield, M.A. Caligiuri and C. Plass, Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci, Blood 97(10) (2001), 3226-3233.
6. J.F. Costello, M.C. Fruhwald, D.J. Smiraglia, L.J. Rush, G.P. Robertson, X. Gao, F.A. Wright, J.D. Feramisco, P. Peltomaki, J.C. Lang, D.E. Schuller, L. Yu, C.D. Bloomfield, M.A. Caligiuri, A. Yates, R. Nishikawa, H. Su Huang, N.J. Petrelli, X. Zhang, M.S. O'Dorisio, W.A. Held, W.K. Cavenee and C. Plass, Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns, Nat Genet 24(2) (2000), 132-138.
7. M.C. Fruhwald, M.S. O'Dorisio, Z. Dai, S.M. Tanner, D.A. Balster, X. Gao, F.A. Wright and C. Plass, Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas- implications for tumor biology and potential clinical utility, Oncogene 20(36) (2001), 5033-5042.
8. S.B. Baylin, J.G. Herman, J.R. Graff, P.M. Vertino and J.P. Issa, Alterations in DNA methylation: a fundamental aspect of neoplasia, Adv Cancer Res 72 (1998), 141-196.
9. S.B. Baylin and J.G. Herman, DNA hypermethylation in tumorigenesis: epigenetics joins genetics, Trends Genet 16(4) (2000), 168-174.
10. P.A. Jones, W.M. Rideout, 3rd, J.C. Shen, C.H. Spruck and Y.C. Tsai, Methylation, mutation and cancer, Bioessays 14(1) (1992), 33-36.
11. F. Larsen, G. Gundersen, R. Lopez and H. Prydz, CpG islands as gene markers in the human genome, Genomics 13(4) (1992), 1095-1107.
12. L.J. Rush and C. Plass, Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications, Anal Biochem 307(2) (2002), 191-201.
13. C. Stirzaker, J.Z. Song, B. Davidson and S.J. Clark, Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells, Cancer Res 64(11) (2004), 3871-3877.
14. L. Di Croce, V.A. Raker, M. Corsaro, F. Fazi, M. Fanelli, M. Faretta, F. Fuks, F. Lo Coco, T. Kouzarides, C. Nervi, S. Minucci and P.G. Pelicci, Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor, Science 295(5557) (2002), 1079-1082.
15. P.S. Yan, H. Shi, F. Rahmatpanah, T.H. Hsiau, A.H. Hsiau, Y.W. Leu, J.C. Liu and T.H. Huang, Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer, Cancer Res 63(19) (2003), 6178-6186.
16. J.R. Graff, J.G. Herman, S. Myohanen, S.B. Baylin and P.M. Vertino, Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation, J Biol Chem 272(35) (1997), 22322-22329.
17. M. Esteller, A. Sparks, M. Toyota, M. Sanchez-Cespedes, G. Capella, M.A. Peinado, S. Gonzalez, G. Tarafa, D. Sidransky, S.J. Meltzer, S.B. Baylin and J.G. Herman, Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer, Cancer Res 60(16) (2000), 4366-4371.
18. K.E. Bachman, J.G. Herman, P.G. Corn, A. Merlo, J.F. Costello, W.K. Cavenee, S.B. Baylin and J.R. Graff, Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers, Cancer Res 59(4) (1999), 798-802.
19. M. Toyota, M. Ohe-Toyota, N. Ahuja and J.P. Issa, Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype, Proc Natl Acad Sci USA 97(2) (2000), 710-715.
20. C. Stirzaker, D.S. Millar, C.L. Paul, P.M. Warnecke, J. Harrison, P.C. Vincent, M. Frommer and S.J. Clark, Extensive DNAmethylation spanning the Rb promoter in retinoblastoma tumors, Cancer Res 57(11) (1997), 2229-2237.
21. G. Deng, A. Chen, J. Hong, H.S. Chae and Y.S. Kim, Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression, Cancer Res 59(9) (1999), 2029-2033.
22. M.L. Gonzalgo, C.M. Bender, E.H. You, J.M. Glendening, J.F. Flores, G.J. Walker, N.K. Hayward, P.A. Jones and J.W. Fountain, Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors, Cancer Res 57(23) (1997), 5336-5347.
23. M. Gonzalez-Zulueta, C.M. Bender, A.S. Yang, T. Nguyen, R.W. Beart, J.M. Van Tornout and P.A. Jones, Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing, Cancer Res 55(20) (1995), 4531-4535.
24. C.A. Eads, K.D. Danenberg, K. Kawakami, L.B. Saltz, P.V. Danenberg and P.W. Laird, CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression, Cancer Res 59(10) (1999), 2302-2306.
25. J.A. Tsou, J.A. Hagen, C.L. Carpenter and I.A. Laird-Offringa, DNA methylation analysis: a powerful new tool for lung cancer diagnosis, Oncogene 21(35) (2002), 5450-5461.
26. C. Goessl, M. Muller, R. Heicappell, H. Krause and K. Miller, DNA-based detection of prostate cancer in blood, urine, and ejaculates, Ann N Y Acad Sci 945 (2001), 51-58.
27. C. Jeronimo, G. Varzim, R. Henrique, J. Oliveira, M.J. Bento, C. Silva, C. Lopes and D. Sidransky, I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma, Cancer Epidemiol Biomarkers Prev 11(5) (2002), 445-450.
28. H. Kim, Y.M. Kwon, J.S. Kim, H. Lee, J.H. Park, Y.M. Shim, J. Han, J. Park and D.H. Kim, Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer, J Clin Oncol 22(12) (2004), 2363-2370.
29. S.S. Potter and J.E. Newbold, Multidimensional restriction enzyme analysis of complex genomes, Anal Biochem 71(2) (1976), 452-458.
30. S.G. Fischer and L.S. Lerman, Length-independent separation of DNA restriction fragments in two-dimensional gel electrophoresis, Cell 16(1) (1979), 191-200.
31. C.W. Chen and C.A. Thomas, Jr., A rapid two-dimensional fractionation of DNA restriction fragments, Anal Biochem 131(2) (1983), 397-403.
32. I. Hatada, Y. Hayashizaki, S. Hirotsune, H. Komatsubara and T. Mukai, A genomic scanning method for higher organisms using restriction sites as landmarks, Proc Natl Acad Sci USA 88(21) (1991), 9523-9527.
33. S.Watanabe, J. Kawai, S. Hirotsune, H. Suzuki, K. Hirose, C. Taga, N. Ozawa, S. Fushiki and Y. Hayashizaki, Accessibility to tissue-specific genes from methylation profiles of mouse brain genomic DNA, Electrophoresis 16(2) (1995), 218-226.
34. D.J. Smiraglia, M.C. Fruhwald, J.F. Costello, S.P. McCormick, Z. Dai, P. Peltomaki, M.S. O'Dorisio, W.K. Cavenee and C. Plass, A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels, Genomics 58(3) (1999), 254-262.
35. J.F. Costello, C. Plass and W.K. Cavenee, Aberrant methylation of genes in low-grade astrocytomas, Brain Tumor Pathol 17(2) (2000), 49-56.
36. C. Plass, D. Weichenhan, J. Catanese, J.F. Costello, F. Yu, L. Yu, D. Smiraglia, W.K. Cavenee, M.A. Caligiuri, P. deJong and W.A. Held, An arrayed human not I-EcoRV boundary library as a tool for RLGS spot analysis, DNA Res 4(3) (1997), 253-255.
37. L. DeMarchis, C. Cropp, Z.M. Sheng, S. Bargo and R. Callahan, Candidate target genes for loss of heterozygosity on human chromosome 17q21, Br J Cancer 90(12) (2004), 2384-2389.
38. J. Zhou, L. Nong, M. Wloch, A. Cantor, J.L. Mulshine and M.S. Tockman, Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer, Lung Cancer 34(3) (2001), 341-350.
39. Y. Ishikawa, R. Furuta, T. Miyoshi, Y. Satoh, S. Okumura, K. Nakagawa and E. Tsuchiya, Loss of heterozygosity and the smoking index increase with decrease in differentiation of lung adenocarcinomas: etiologic implications, Cancer Lett 187(1-2) (2002), 47-51.
40. W.L. Ho, J.W. Chang, R.C. Tseng, J.T. Chen, C.Y. Chen, Y.S. Jou and Y.C.Wang, Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer, Cancer Detect Prev 26(5) (2002), 343-349.
41. Z. Dai, R.R. Lakshmanan, W.G. Zhu, D.J. Smiraglia, L.J. Rush, M.C. Fruhwald, R.M. Brena, B. Li, F.A. Wright, P. Ross, G.A. Otterson and C. Plass, Global methylation profiling of lung cancer identifies novel methylated genes, Neoplasia 3(4) (2001), 314-323.
42. D.J. Smiraglia, L.T. Smith, J.C. Lang, L.J. Rush, Z. Dai, D.E. Schuller and C. Plass, Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC), J Med Genet 40(1) (2003), 25-33.
43. D.J. Smiraglia, J. Szymanska, S.M. Kraggerud, R.A. Lothe, P. Peltomaki and C. Plass, Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors, Oncogene 21(24) (2002), 3909-3916.
44. M. Gardiner-Garden and M. Frommer, CpG islands in vertebrate genomes, J Mol Biol 196(2) (1987), 261-282.
45. Y. Kondo, L. Shen, P.S. Yan, T.H. Huang and J.P. Issa, Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation, Proc Natl Acad Sci USA 101(19) (2004), 7398-7403.